Upstream Biotechnology, Inc. — Form D
Upstream Biotechnology, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2025-09-17. The offering totals $1.6M, of which $625K was reported sold. Industry: Other Technology.
Offering
- Filed: 2025-09-17
- Form: D
- Accession: 0002086249-25-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $625K
- Remaining: $1.0M
- Investors: 3
- Date of first sale: 2025-08-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-557862
Issuer
- Name: Upstream Biotechnology, Inc.
- CIK: 0002086249
- Entity type: Corporation
- Jurisdiction: NORTH CAROLINA
- Address: 701 W. MAIN STREET, SUITE 200, DURHAM, NC, 27701
- Phone: 252-551-1088
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Xinnian H Dong | Director | Durham, NC |
| George H Greene | Director | Durham, NC |
| Karen H LeVert | Director | Durham, NC |
| Xiao-fang H Wang | Director | Durham, NC |
| George H Greene | Executive Officer | Durham, NC |
More